NCT04812210View on ClinicalTrials.gov

Quality of Life and Neurodevelopment Assessment of Children With Congenital Heart Disease Aged 2 to 4 Years

CompletedOBSERVATIONAL

Enrollment

248

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

December 30, 2021

Conditions

Congenital Heart Disease

Trial Locations (1)

34295

Uh Montpellier, Montpellier

All Listed Sponsors

collaborator

University of Montpellier - Inserm 1046 - PhyMeddExp

UNKNOWN

collaborator

Saint Pierre Institute - Palavas les Flots

UNKNOWN

collaborator

University Hospital, Bordeaux

OTHER

lead

University Hospital, Montpellier

OTHER

NCT04812210 - Quality of Life and Neurodevelopment Assessment of Children With Congenital Heart Disease Aged 2 to 4 Years | Biotech Hunter | Biotech Hunter